Shugufa Afifi's Colleagues at QED Therapeutics
Shugufa Afifi's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Shugufa Afifi's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Shugufa Afifi
Shugufa Afifi currently works for QED Therapeutics.
Shugufa Afifi's role at QED Therapeutics is Clinical Trial Manager.
Shugufa Afifi's email address is ***@qedtx.com. To view Shugufa Afifi's full email address, please signup to ConnectPlex.
Shugufa Afifi works in the Biotechnology industry.
Shugufa Afifi's colleagues at QED Therapeutics are Chelsea Wolfe, Dr.Meenakshi Srivastava, Jacob Mercer, Liz Bergan, Brett Kuenne, Vermali Rodriguez, Kathleen Guindon and others.
Shugufa Afifi's phone number is 650-231-4088